Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany
Clinical trial NCT04444804 · COMPLETED
Trial details
- NCT number
- NCT04444804
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-31
- Primary completion
- 2021-04-30
- Enrollment
- 22153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.